Brendan Smith
Stock Analyst at TD Cowen
(1.83)
# 3,307
Out of 5,241 analysts
18
Total ratings
45.45%
Success rate
2.62%
Average return
Main Sectors:
Stocks Rated by Brendan Smith
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PASG Passage Bio | Downgrades: Hold | n/a | $5.22 | - | 1 | Apr 21, 2026 | |
| SLP Simulations Plus | Maintains: Hold | $19 → $16 | $13.34 | +19.94% | 3 | Apr 10, 2026 | |
| DNA Ginkgo Bioworks Holdings | Maintains: Buy | $14 → $12 | $7.71 | +55.64% | 2 | Jan 8, 2026 | |
| TWST Twist Bioscience | Maintains: Buy | $32 → $43 | $49.17 | -12.55% | 1 | Jan 8, 2026 | |
| SDGR Schrödinger | Maintains: Buy | $33 → $24 | $11.95 | +100.84% | 1 | Jan 8, 2026 | |
| CTKB Cytek Biosciences | Maintains: Buy | $4 → $5 | $3.41 | +46.84% | 1 | Jan 8, 2026 | |
| AZTA Azenta | Maintains: Hold | $35 → $39 | $16.02 | +143.45% | 1 | Jan 8, 2026 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $79 → $90 | $67.12 | +34.09% | 3 | Jan 8, 2026 | |
| NVAX Novavax | Maintains: Hold | $8 → $7 | $9.06 | -22.74% | 2 | Nov 4, 2025 | |
| WST West Pharmaceutical Services | Initiates: Buy | $350 | $302.89 | +15.55% | 1 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $76.67 | - | 1 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $18.62 | - | 1 | Dec 5, 2022 |
Passage Bio
Apr 21, 2026
Downgrades: Hold
Price Target: n/a
Current: $5.22
Upside: -
Simulations Plus
Apr 10, 2026
Maintains: Hold
Price Target: $19 → $16
Current: $13.34
Upside: +19.94%
Ginkgo Bioworks Holdings
Jan 8, 2026
Maintains: Buy
Price Target: $14 → $12
Current: $7.71
Upside: +55.64%
Twist Bioscience
Jan 8, 2026
Maintains: Buy
Price Target: $32 → $43
Current: $49.17
Upside: -12.55%
Schrödinger
Jan 8, 2026
Maintains: Buy
Price Target: $33 → $24
Current: $11.95
Upside: +100.84%
Cytek Biosciences
Jan 8, 2026
Maintains: Buy
Price Target: $4 → $5
Current: $3.41
Upside: +46.84%
Azenta
Jan 8, 2026
Maintains: Hold
Price Target: $35 → $39
Current: $16.02
Upside: +143.45%
Halozyme Therapeutics
Jan 8, 2026
Maintains: Buy
Price Target: $79 → $90
Current: $67.12
Upside: +34.09%
Novavax
Nov 4, 2025
Maintains: Hold
Price Target: $8 → $7
Current: $9.06
Upside: -22.74%
West Pharmaceutical Services
Oct 29, 2025
Initiates: Buy
Price Target: $350
Current: $302.89
Upside: +15.55%
Jul 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $76.67
Upside: -
Dec 5, 2022
Initiates: Outperform
Price Target: n/a
Current: $18.62
Upside: -